Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine (CoronaVac) in healthy children and adolescents: a double-blind, randomised, controlled, phase 1/2 clinical trial.

ABSTRACT:

SUBMITTER: Han B 

PROVIDER: S-EPMC8238449 | biostudies-literature | 2021 Dec

REPOSITORIES: biostudies-literature